RUS ENG
Grant of the Government of the Russian Federation for the state support of scientific researches, which are conducted under the guidance of leading scientists in Russian educational institutions of higher professional education (agreement No. 11.G34.31.0065 dated October 19, 2011)
Regeneration of airways and lung
The official website of the project "Investigating the molecular mechanisms and underlying pathways of regenerative medicine approaches the tissue-engineering and cell therapy of airways and lungs"
| |
| |
Events and announcements | |
| |
| |
| |
| |
| |
| |
|
Main pageDecember 11, 2013: International Symposium and the 4thRegenerative Medicine School for Young Scientists “Organs and Tissues Regeneration” was conducted on the basis of the International Research, Clinical and Educational Center of Regenerative Medicine
Professor Doris Taylor, Regenerative Medicine Research Director of the Texas Heart Institute (USA, Texas), delivered a keynote lecture.
Doris Taylor is regarded as the heart regeneration pioneer. Together with her collaborators, she managed to perform “complete decellularization” of lab animal and human hearts. Then the scaffold re-seed with stem cells partially acquired the properties and functional parameters of a regenerated beating heart. That is the first visit of Doris Taylor to Russia. Her lecture is called “Engineering human lung and heart tissues”.
The reporters include Professor of Karolinska Institute and Kuban State Medical University Paolo Macchiarini. His presentation is devoted to the progress of airway regeneration project implemented in the frames of Megagrant and plans for the next two years.
The other speakers are: Professor Sergey Chvalun, Head of the Polymer Materials Laboratory of the Kurchatov Institute; Professor Sergey Orlov, Director of the Medical Primatology Research Institute of the Russian Academy of Medical Sciences; Professor Vladimir Porkhanov, Associate Member of the Russian Academy of Medical Sciences, Head Physician of Regional clinical hospital No.1; and David Green, CEO, Harvard Apparatus Regenerative Technology (Holliston, USA).